MedTrace Logo

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

NCT06990568 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-05-25

No results posted yet for this study

Summary

The study goal is to determine whether oral administration of a probiotic mixture can reduce the incidence of antibiotic-associated diarrhea in patients with community-acquired pneumonia.

Conditions

Interventions

DRUG

Lacidofil

1 capsule twice daily.

DRUG

Placebo

1 capsule twice daily.

Sponsors & Collaborators

  • National Health Insurance Service Ilsan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-05-31
Completion
2026-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06990568 on ClinicalTrials.gov